{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:58:24Z","timestamp":1789646304261,"version":"4.0.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["AI105170"],"award-info":[{"award-number":["AI105170"]}]},{"name":"NIH\/NIAID","award":["AI093772"],"award-info":[{"award-number":["AI093772"]}]},{"name":"NIH\/NIAID","award":["P30AI050409"],"award-info":[{"award-number":["P30AI050409"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.antiviral.2014.07.016","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T19:32:02Z","timestamp":1407439922000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis"],"prefix":"10.1016","volume":"110","author":[{"given":"Hye Suk","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Man","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Eun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Na","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Kyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 9","key":"10.1016\/j.antiviral.2014.07.016_b0005","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1099\/0022-1317-73-9-2225","article-title":"Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus","volume":"73","author":"Arbiza","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0010","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0264-410X(00)00213-9","article-title":"Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice","volume":"19","author":"Boelen","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.07.016_b0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1203\/00006450-200209000-00009","article-title":"Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity","volume":"52","author":"Bont","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.antiviral.2014.07.016_b0020","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.4049\/jimmunol.181.10.6692","article-title":"Cutting edge: eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease","volume":"181","author":"Castilow","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0025","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1128\/JVI.01949-07","article-title":"Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus","volume":"82","author":"Castilow","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0264-410X(92)90397-3","article-title":"Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia\u2013RSV recombinants or RSV","volume":"10","author":"Connors","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.07.016_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.07.016_b0040","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1086\/430008","article-title":"Respiratory syncytial virus load predicts disease severity in previously healthy infants","volume":"191","author":"DeVincenzo","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.016_b0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1086\/314947","article-title":"Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge","volume":"180","author":"Fischer","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.016_b0050","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.4049\/jimmunol.1000423","article-title":"Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection","volume":"185","author":"Fulton","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3851\/IMP2061","article-title":"Antibodies for prevention and treatment of respiratory syncytial virus infections in children","volume":"17","author":"Geevarghese","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2014.07.016_b0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2010.00972.x","article-title":"Biological challenges and technological opportunities for respiratory syncytial virus vaccine development","volume":"239","author":"Graham","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2014.07.016_b0065","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI115362","article-title":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice","volume":"88","author":"Graham","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2014.07.016_b0070","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/S0264-410X(01)00228-6","article-title":"CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)","volume":"19","author":"Hancock","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.07.016_b0075","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.78.11.6024-6032.2004","article-title":"Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV","volume":"78","author":"Johnson","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0080","doi-asserted-by":"crossref","first-page":"e36812","DOI":"10.1371\/journal.pone.0036812","article-title":"Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice","volume":"7","author":"Kamphuis","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.07.016_b0085","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1586\/erv.12.70","article-title":"Virus-like particles as universal influenza vaccines","volume":"11","author":"Kang","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2014.07.016_b0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0095","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/514138","article-title":"Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children","volume":"176","author":"Karron","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.016_b0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/vim.1987.1.199","article-title":"Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children","volume":"1","author":"Kasel","year":"1987","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0110","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1128\/JVI.01036-09","article-title":"Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus","volume":"83","author":"Kohlmann","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/JVI.01861-10","article-title":"Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins","volume":"85","author":"McGinnes","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0192623308329342","article-title":"Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model","volume":"37","author":"Meyerholz","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0125","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/JVI.01709-09","article-title":"Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB\/c mice, with no evidence of immunopathology","volume":"84","author":"Murawski","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","article-title":"Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3\u20136 months after immunization","volume":"8","author":"Murphy","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.07.016_b0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/524019","article-title":"Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya","volume":"46","author":"Nokes","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.016_b0140","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/01.inf.0000053893.15894.ff","article-title":"Clinical experience with respiratory syncytial virus vaccines","volume":"22","author":"Piedra","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2014.07.016_b0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.07.016_b0150","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0155","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/infdis\/jir474","article-title":"Virus like particle vaccine induces protection against respiratory syncytial virus infection in mice","volume":"204","author":"Quan","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.016_b0160","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01510-12","article-title":"Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains","volume":"86","author":"Schmidt","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/498246","article-title":"Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya","volume":"193","author":"Scott","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.016_b0170","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.vaccine.2012.11.006","article-title":"The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease","volume":"31","author":"Shaw","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.07.016_b0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2010.05.034","article-title":"Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles","volume":"405","author":"Song","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.07.016_b0180","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1128\/JVI.01347-13","article-title":"The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection","volume":"87","author":"Stokes","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0185","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2007.07.025","article-title":"Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus","volume":"25","author":"Ternette","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.07.016_b0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/rmv.518","article-title":"Immunopathology of RSV infection: prospects for developing vaccines without this complication","volume":"17","author":"van Drunen Littel-van den Hurk","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/14760584.5.2.261","article-title":"Prevention and treatment of respiratory syncytial virus infection in infants: an update","volume":"5","author":"Venkatesh","year":"2006","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2014.07.016_b0200","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JVI.70.5.2852-2860.1996","article-title":"Respiratory syncytial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern","volume":"70","author":"Waris","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0205","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.4049\/jimmunol.1100764","article-title":"Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection","volume":"187","author":"Weiss","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0210","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1086\/339822","article-title":"Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus","volume":"185","author":"Wright","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.016_b0215","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/j.vaccine.2007.08.014","article-title":"The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines","volume":"25","author":"Wright","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.07.016_b0220","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","article-title":"Construction and characterization of virus-like particles: a review","volume":"53","author":"Zeltins","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.antiviral.2014.07.016_b0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.virusres.2012.06.003","article-title":"Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines","volume":"167","author":"Zeng","year":"2012","journal-title":"Virus Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T20:54:20Z","timestamp":1598129660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":45,"alternative-id":["S0166354214002150"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}